L. Bjermer, E. Kerwin, F. Maltais, P. Jones, I. Boucot, L. Tombs, I. Naya, M. Watkins, David A. Lipson, C. Compton, C. Vogelmeier
{"title":"Umeclidinium/Vilanterol, Umeclidinium和沙美特罗在症状性Maintenance-Naïve和维持治疗的慢性阻塞性肺疾病中的比较疗效和安全性:EMAX试验的预先指定的次要分析","authors":"L. Bjermer, E. Kerwin, F. Maltais, P. Jones, I. Boucot, L. Tombs, I. Naya, M. Watkins, David A. Lipson, C. Compton, C. Vogelmeier","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3317","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":"{\"title\":\"Comparative Efficacy and Safety of Umeclidinium/Vilanterol, Umeclidinium and Salmeterol in Symptomatic Maintenance-Naïve and Maintenance-Treated Chronic Obstructive Pulmonary Disease: A Pre-Specified Secondary Analysis of the EMAX Trial\",\"authors\":\"L. Bjermer, E. Kerwin, F. Maltais, P. Jones, I. Boucot, L. Tombs, I. Naya, M. Watkins, David A. Lipson, C. Compton, C. Vogelmeier\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3317\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":311626,\"journal\":{\"name\":\"B45. COPD: TREATMENT\",\"volume\":\"6 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B45. COPD: TREATMENT\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3317\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B45. COPD: TREATMENT","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3317","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Comparative Efficacy and Safety of Umeclidinium/Vilanterol, Umeclidinium and Salmeterol in Symptomatic Maintenance-Naïve and Maintenance-Treated Chronic Obstructive Pulmonary Disease: A Pre-Specified Secondary Analysis of the EMAX Trial